retatrutide ly3437943 triple agonist glp-1 gip glucagon LY3437943, a novel glucagon, GIP, and receptor for glycemic control and weight loss: From discovery to clinical proof of concept Retatrutide Explained: How the Triple

Unlike quick fixes, this formula harnesses clinically studied ingredients that help your body burn fat for energy, balance blood sugar levels, and minimize fat accumulation while preserving lean mass

This is where wellness starts to collide with pharma

Incretin based therapies with glucagon-like peptide-1 receptor agonists (GLP-1RA) are already established in the treatment of type 2 diabetes

This advanced formula features targeted probiotic strains including Akkermansia muciniphila and Clostridium butyricum, organisms associated with gut barrier integrity, short-chain fatty acid production, and healthy microbiome diversity

You may have been reading a lot about newly launched obesity drugs and I covered some of this in my podcast last year with Stephan Guyenet in anticipation